Literature DB >> 29654480

Optimizing right ventricular focused four-chamber views using three-dimensional imaging, a comparative magnetic resonance based study.

Myriam Amsallem1,2,3, HongQuan Lu4,5, Xiu Tang4, Nadia L Do Couto Francisco4, Yukari Kobayashi4,5, Kegan Moneghetti4,5, Hadas Shiran4, Ian Rogers4,5, Ingela Schnittger4,5, David Liang4,5, François Haddad4,5.   

Abstract

Obtaining focused right ventricular (RV) apical view remains challenging using conventional two-dimensional (2D) echocardiography. This study main objective was to determine whether measurements from RV focused views derived from three-dimensional (3D) echocardiography (3D-RV-focused) are closely related to measurements from magnetic resonance (CMR). A first cohort of 47 patients underwent 3D echocardiography and CMR imaging within 2 h of each other. A second cohort of 25 patients had repeat 3D echocardiography to determine the test-retest characteristics; and evaluate the bias associated with unfocused RV views. Tomographic views were extracted from the 3D dataset: RV focused views were obtained using the maximal RV diameter in the transverse plane, and unfocused views from a smaller transverse diameter enabling visualization of the tricuspid valve opening. Measures derived using the 3D-RV-focused view were strongly associated with CMR measurements. Among functional metrics, the strongest association was between RV fractional area change (RVFAC) and ejection fraction (RVEF) (r = 0.92) while tricuspid annular plane systolic excursion moderately correlated with RVEF (r = 0.47), all p < 0.001. Among RV size measures, the strongest association was found between RV end-systolic area (RVESA) and volume (r = 0.87, p < 0.001). RV unfocused views led on average to 10% underestimation of RVESA. The 3D-RV-focused method had acceptable test-retest characteristics with a coefficient of variation of 10% for RVESA and 11% for RVFAC. Deriving standardized RV focused views using 3D echocardiography strongly relates to CMR-derived measures and may improve reproducibility in RV 2D measurements.

Entities:  

Keywords:  Cardiac magnetic resonance; Quality control; Right heart imaging; Three-dimensional echocardiography

Mesh:

Year:  2018        PMID: 29654480     DOI: 10.1007/s10554-018-1356-7

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  11 in total

1.  EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography.

Authors:  Roberto M Lang; Luigi P Badano; Wendy Tsang; David H Adams; Eustachio Agricola; Thomas Buck; Francesco F Faletra; Andreas Franke; Judy Hung; Leopoldo Pérez de Isla; Otto Kamp; Jaroslaw D Kasprzak; Patrizio Lancellotti; Thomas H Marwick; Marti L McCulloch; Mark J Monaghan; Petros Nihoyannopoulos; Natesa G Pandian; Patricia A Pellikka; Mauro Pepi; David A Roberson; Stanton K Shernan; Girish S Shirali; Lissa Sugeng; Folkert J Ten Cate; Mani A Vannan; Jose Luis Zamorano; William A Zoghbi
Journal:  J Am Soc Echocardiogr       Date:  2012-01       Impact factor: 5.251

Review 2.  ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology.

Authors:  Robert C Hendel; Manesh R Patel; Christopher M Kramer; Michael Poon; Robert C Hendel; James C Carr; Nancy A Gerstad; Linda D Gillam; John McB Hodgson; Raymond J Kim; Christopher M Kramer; John R Lesser; Edward T Martin; Joseph V Messer; Rita F Redberg; Geoffrey D Rubin; John S Rumsfeld; Allen J Taylor; Wm Guy Weigold; Pamela K Woodard; Ralph G Brindis; Robert C Hendel; Pamela S Douglas; Eric D Peterson; Michael J Wolk; Joseph M Allen; Manesh R Patel
Journal:  J Am Coll Cardiol       Date:  2006-10-03       Impact factor: 24.094

3.  [Association between echocardiography derived right ventricular function parameters with cardiac magnetic resonance derived right ventricular ejection fraction and 6-minute walk distance in pulmonary hypertension patients].

Authors:  Zhenzhen Wang; Zhenwen Yang; Zheng Wan; Tielian Yu; Lili Jia; Xin Du; Canliang Huang
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2014-09

4.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Roberto M Lang; Luigi P Badano; Victor Mor-Avi; Jonathan Afilalo; Anderson Armstrong; Laura Ernande; Frank A Flachskampf; Elyse Foster; Steven A Goldstein; Tatiana Kuznetsova; Patrizio Lancellotti; Denisa Muraru; Michael H Picard; Ernst R Rietzschel; Lawrence Rudski; Kirk T Spencer; Wendy Tsang; Jens-Uwe Voigt
Journal:  J Am Soc Echocardiogr       Date:  2015-01       Impact factor: 5.251

5.  Relationship between echocardiographic and cardiac magnetic resonance imaging-derived measures of right ventricular function in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Yi-dan Li; Yi-dan Wang; Zhen-guo Zhai; Xiao-juan Guo; Ya-feng Wu; Yuan-hua Yang; Xiu-zhang Lu
Journal:  Thromb Res       Date:  2015-01-09       Impact factor: 3.944

6.  Relationship between echocardiographic and magnetic resonance derived measures of right ventricular size and function in patients with pulmonary hypertension.

Authors:  Hadas Shiran; Roham T Zamanian; Michael V McConnell; David H Liang; Rajesh Dash; Shahriar Heidary; Naga Lakshmi Sudini; Joseph C Wu; Francois Haddad; Phillip C Yang
Journal:  J Am Soc Echocardiogr       Date:  2014-01-18       Impact factor: 5.251

7.  Traditional and innovative echocardiographic parameters for the analysis of right ventricular performance in comparison with cardiac magnetic resonance.

Authors:  Marta Focardi; Matteo Cameli; Salvatore Francesco Carbone; Alberto Massoni; Raffaella De Vito; Matteo Lisi; Sergio Mondillo
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-09-03       Impact factor: 6.875

8.  Regional right ventricular dysfunction in acute pulmonary embolism: relationship with clot burden and biomarker profile.

Authors:  Mirela Tuzovic; Sasikanth Adigopula; Myriam Amsallem; Yukari Kobayashi; Michael Kadoch; David Boulate; Gomathi Krishnan; David Liang; Ingela Schnittger; Dominik Fleischmann; Michael V McConnell; François Haddad
Journal:  Int J Cardiovasc Imaging       Date:  2015-10-01       Impact factor: 2.357

Review 9.  Right heart imaging in patients with heart failure: a tale of two ventricles.

Authors:  Myriam Amsallem; Tatiana Kuznetsova; Kate Hanneman; Andre Denault; François Haddad
Journal:  Curr Opin Cardiol       Date:  2016-09       Impact factor: 2.161

10.  Echocardiographic parameters in patients with pulmonary arterial hypertension: correlations with right ventricular ejection fraction derived from cardiac magnetic resonance and hemodynamics.

Authors:  Tao Yang; Yu Liang; Yan Zhang; Qing Gu; Guo Chen; Xin-Hai Ni; Xiu-Zhang Lv; Zhi-Hong Liu; Chang-Ming Xiong; Jian-Guo He
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

View more
  2 in total

1.  Echocardiographic evaluations of right ventriculo-arterial coupling in experimental and clinical pulmonary hypertension.

Authors:  David Boulate; Myriam Amsallem; Tatiana Kuznetsova; Roham T Zamanian; Elie Fadel; Olaf Mercier; Francois Haddad
Journal:  Physiol Rep       Date:  2019-12

2.  Right ventricular ejection fraction as predictor of outcome in acute heart failure using RV ellipsoid model: A retrospective analysis of a prospective cross-sectional study.

Authors:  Eshan Ashcroft; Otar Lazariashvili; Jonathan Belsey; Max Berrill; Pankaj Sharma; Aigul Baltabaeva
Journal:  JRSM Cardiovasc Dis       Date:  2021-03-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.